Increasing survival of free tissue grafts and flaps using phosphodiesterase type 5 (PDE5) inhibitors
The present invention relates to methods of tissue grafting and microvascular free flap transfer that involve administering a phosphodiesterase type-5 inhibitor to the tissue graft or microvascular free flap to produce a treated graft or flap, and implanting the treated graft or flap into a recipien...
Saved in:
| Format | Patent |
|---|---|
| Language | English |
| Published |
17.04.2018
|
| Online Access | Get full text |
Cover
Loading…
| Summary: | The present invention relates to methods of tissue grafting and microvascular free flap transfer that involve administering a phosphodiesterase type-5 inhibitor to the tissue graft or microvascular free flap to produce a treated graft or flap, and implanting the treated graft or flap into a recipient site of a host subject. |
|---|